在异性干细胞移植后的捐赠者衍生的恶性瘤:一种罕见但已知的并发症
Panagiotis Tsirigotis1,2, Ioanna Lazana3
1Hematology Department, Attikon General University Hospital, Athens, Greece.
Bone marrow transplantation
|September 27, 2025
概括
捐赠者衍生的恶性瘤 (DDM) 在异性干细胞移植 (allo-SCT) 后是一个新兴的问题. 本综述分析了2009年至2024年的DDM病例,以确定易感因素并告知临床管理.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 移植医学 移植医学
背景情况:
- 复发后异构干细胞移植 (allo-SCT) 影响30-60%的患者,通常来自原始恶性克隆.
- 源自捐赠者的恶性瘤 (DDM),恶性瘤来自捐赠细胞,由于先进的嵌合体分析,越来越多地被认可.
- 区分DDM与原始疾病复发对于适当的治疗和理解对捐赠者的伦理影响至关重要.
研究的目的:
- 系统地审查和分析2009年至2024年期间报告的源于捐赠者的恶性瘤 (DDM) 病例.
- 确定与DDM发展相关的潜在共同特征或风险因素.
- 自2009年最后一份综合报告以来,更新对DDM发生率和特征的理解.
主要方法:
- 报告的DDM病例的系统文献审查.
- 对2009年至2024年报告的病例进行分析.
- 对患者和捐赠者的特征,遗传发现和临床结果进行批判性评估.
主要成果:
- 报告的DDM病例的发生率一直在增加.
- 对最近病例的分析旨在揭示患者,捐赠者或移植因子的共同点.
- 与最初的复发相比,预计DDM的临床表现和结果将不同.
结论:
- 了解DDM对于完善allo-SCT协议和患者护理至关重要.
- 鉴定易感因素可能会导致改善捐赠者查和风险分层.
- 需要进一步研究以阐明DDM的机制和优化DDM的管理策略.
更多相关视频
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.8K
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
8.3K
相关概念视频
Bone Marrow Sampling and Transplants
886
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
886
Tissue Transplantation
921
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
921
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Cell-mediated Immune Responses
83.5K
Overview
83.5K
Kidney Transplant I: Introduction
343
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
343
